Recently, Jiudian Hongyang's API Dexketoprofen Tromethamine (Y20210000881) officially obtained the marketing approval from CDE, and its registration status was successfully transferred to "A".

Dexketoprofen Tromethamine is a water-soluble tromethamine salt of the dextrorotatory enantiomer of the non-steroidal anti-inflammatory drug ketoprofen. It has obvious anti-inflammatory, antipyretic and analgesic effects. It is mainly used to treat mild to moderate pain and inflammation, such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gouty arthritis, as well as dysmenorrhea, toothache, postoperative pain, cancer pain, acute sprains, soft tissue contusion pain, and systemic pain caused by colds and fever. It has the characteristics of low gastrointestinal toxicity and rapid and complete absorption after oral administration.

Dexketoprofen tromethamine tablets or injections can be used to relieve moderate to severe postoperative pain, including abdominal, chest, gynecological, oral, orthopedic and urological surgeries, as well as acute renal colloid pain, biliary colic, toothache, traumatic pain, trigeminal neuralgia, cancer visceral pain, and all kinds of pain syndromes that previously required morphine or pethidine to take effect; dexketoprofen tromethamine capsules are suitable for the treatment of mild to moderate pain of different causes. Data show that the sales of dexketoprofen tromethamine preparations in 2023 were about 40 million yuan. In the same year, dexketoprofen tromethamine injection was included in the national medical insurance, which has a broad market space in China.

Jiudian Hongyang's NSAIDs licensed by CDE include Flurbiprofen, Ketoprofen, Loxoprofen Sodium, etc. The approval of Dexketoprofen Tromethamine is a strong proof of the technical level and product quality of the company, which can further improve the competitiveness of the company in the industry, satisfy the market demand, and add to the analgesic and anti-inflammatory series of drugs of the company. Jiudian Hongyang will keep up the good work and provide more high-quality APIs and excipients and services for the preparation enterprises.